BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 22520847)

  • 21. Transcriptional regulation of pattern recognition receptors by Jak/STAT signaling, and the implications for disease pathogenesis.
    Jenkins BJ
    J Interferon Cytokine Res; 2014 Oct; 34(10):750-8. PubMed ID: 25051239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonizing cytokine-mediated JAK-STAT signaling by porcine reproductive and respiratory syndrome virus.
    Yang L; Zhang YJ
    Vet Microbiol; 2017 Sep; 209():57-65. PubMed ID: 28069291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and consequences of Jak-STAT signaling in the immune system.
    Villarino AV; Kanno Y; O'Shea JJ
    Nat Immunol; 2017 Mar; 18(4):374-384. PubMed ID: 28323260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT signaling in the intestine.
    Nobel YR; Stier K; Krishnareddy S
    Int Rev Cell Mol Biol; 2021; 361():1-20. PubMed ID: 34074491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology and significance of the JAK/STAT signalling pathways.
    Kiu H; Nicholson SE
    Growth Factors; 2012 Apr; 30(2):88-106. PubMed ID: 22339650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation.
    Gotthardt D; Trifinopoulos J; Sexl V; Putz EM
    Front Immunol; 2019; 10():2590. PubMed ID: 31781102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulation of JAKs in cytokine signaling and its breakdown in disease.
    Hammarén HM; Virtanen AT; Raivola J; Silvennoinen O
    Cytokine; 2019 Jun; 118():48-63. PubMed ID: 29685781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
    Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.
    Liu MQ; Zhou DJ; Wang X; Zhou W; Ye L; Li JL; Wang YZ; Ho WZ
    PLoS One; 2012; 7(4):e35902. PubMed ID: 22558263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
    Ezeonwumelu IJ; Garcia-Vidal E; Ballana E
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects.
    Flamant M; Rigaill J; Paul S; Roblin X
    Drugs; 2017 Jul; 77(10):1057-1068. PubMed ID: 28523588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
    Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
    J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling.
    Chaimowitz NS; Forbes LR
    Curr Opin Pediatr; 2019 Dec; 31(6):843-850. PubMed ID: 31693596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.
    Luo Y; Alexander M; Gadina M; O'Shea JJ; Meylan F; Schwartz DM
    J Allergy Clin Immunol; 2021 Oct; 148(4):911-925. PubMed ID: 34625141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAK/STAT pathway modulation: Does it work in dermatology?
    Gündüz Ö
    Dermatol Ther; 2019 May; 32(3):e12903. PubMed ID: 30964573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.